ADOPTIVE CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA BASED ON T CELLS REDIRECTED TOWARD TUMOR CELLS BY PRAME SPECIFIC αβTCR GENE MODIFICATION

被引：0

作者：

Caruana, Ignazio ^{[1
]}

Orlando, Domenico ^{[1
]}

De Angelis, Biagio ^{[1
]}

Boffa, Iolanda ^{[1
]}

Guercio, Marika ^{[1
]}

Carai, Andrea ^{[2
]}

Massimi, Luca ^{[6
]}

Ferretti, Elisabetta ^{[3
]}

Miele, Evelina ^{[3
]}

Po, Agnese ^{[3
]}

Moseley, Annemarie ^{[4
]}

Hagedoorn, R. S. ^{[5
]}

de Boer, R. ^{[5
]}

Falkenburg, J. H. Frederik ^{[5
]}

Heemskerk, Mirjam H. M. ^{[5
]}

Locatelli, Franco ^{[1
]}

Mastronuzzi, Angela ^{[1
]}

Quintarelli, Concetta ^{[1
]}

机构：

[1] IRCCS Osped Pediat Bambino Gesu, Dept Pediat Hematol & Oncol, Rome, Italy

[2] IRCCS Osped Pediat Bambino Gesu, Dept Neurosci & Neurorehabil, Neurosurg Unit, Rome, Italy

[3] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy

[4] Bellicum Pharmaceut Inc, Houston, TX USA

[5] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands

[6] Catholic Univ, Sch Med, Dept Neurosurg, Paediat Neurosurg, Rome, Italy

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MB-64

引用

页码：111 / 111

页数：1

共 50 条

[21] TCR engineered T cells for solid tumor immunotherapy
Yikai Zhang
Zhipeng Liu
Wei Wei
Yangqiu Li
Experimental Hematology & Oncology, 11
[22] Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Nadia Mensali
Marit Renée Myhre
Pierre Dillard
Sylvie Pollmann
Gustav Gaudernack
Gunnar Kvalheim
Sébastien Wälchli
Else Marit Inderberg
Cancer Immunology, Immunotherapy, 2020, 69 : 159 - 161
[23] Epigenetic modification of antitumor T cells for optimal adoptive immunotherapy
Yoshikawa, Toshiaki
Wu, Zhiwen
Matsushita, Hirokazu
Hosoda, Waki
Suzuki, Shiro
Kagoya, Yuki
CANCER SCIENCE, 2022, 113
[24] Genetic modification of antitumor T cells for improved adoptive immunotherapy
Kagoya, Yuki
CANCER SCIENCE, 2022, 113 : 646 - 646
[25] Natural killer T cells may have an important role in adoptive immunotherapy with tumor-specific T cells
不详
IMMUNOTHERAPY, 2009, 1 (05) : 735 - 736
[26] Human effector T cells derived from central memory cells rather than CD8+T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy
Wu, Fenglin
Zhang, Wenfeng
Shao, Hongwei
Bo, Huaben
Shen, Han
Li, Jiandong
Liu, Yichen
Wang, Teng
Ma, Wenli
Huang, Shulin
CANCER LETTERS, 2013, 339 (02) : 195 - 207
[27] Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy
Parlar, A.
Pamukcu, C.
Ozkazanc, D.
Aras, M.
Dahlberg, C.
Chrobok, M.
Zahedimaram, P.
Ikromzoda, L.
Sayitoglu, E. C.
Alici, E.
Erman, B.
Duru, A. D.
Sutlu, T.
HUMAN GENE THERAPY, 2017, 28 (12) : A31 - A32
[28] Capture and generation of adenovirus specific T cells for adoptive immunotherapy
Chatziandreou, Enia
Gilmour, Kimberly C.
McNicol, Anne-Marie
Costabile, Maurizio
Sinclair, Joanna
Cubitt, David
Campbell, John D. M.
Kinnon, Christine
Qasim, Waseem
Gaspar, H. Bobby
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 117 - 126
[29] Alloreactivity as a source of high avidity T cell clones specific for cancer testis-antigens associated with multiple myeloma: Prospects for adoptive immunotherapy with primary T cells redirected toward multiple myeloma by T cell receptor gene transfer.
Kronig, Holger
Hofer, Kathrin
Neudorfer, Julia
Peschel, Christian
Bernhard, Helga
BLOOD, 2006, 108 (11) : 1060A - 1060A
[30] Blood donor derived dendritic cells and cytotoxic T cells for specific fusion-gene adoptive immunotherapy
Gallagher, R. C. J.
Waterfall, M.
Samuel, K.
Turner, M. L.
VOX SANGUINIS, 2007, 92 (04) : 351 - 360

← 1 2 3 4 5 →